1) Invo Bioscience Inc

NASDAQ: INVO

2.47 USD +1.93 (357.41%) today

Track all markets on TradingView


  • Fertility service provider INVO Bioscience (NASDAQ:INVO) announced an agreement on Monday to acquire the oncology and regenerative medicine company NAYA Biosciences in an all-stock transaction.
  • INVO (INVO) shares surged ~115% pre-market after the announcement.
  • Per the terms, NAYA investors will receive ~18.2M INVO shares in a ratio of 7.3 for each NAYA share, and after the transaction, they will own 88% of the combined entity, with INVO shareholders holding the rest.
  • The combined company will trade on the Nasdaq as "NAYA Biosciences." Dr. Daniel Teper, the current chairman and CEO of NAYA Biosciences is expected to take over its leadership.
  • The deal is set to be completed in Q4 2023, subject to closing conditions, including shareholder approval and an interim private financing round in INVO valued at least $5M.

‍

Disclaimer: This video is made for entertainment purposes only. This is not financial advice.